On December 7, 2023, the Biden administration announced a blueprint for a framework that may be a tough pill to swallow for the pharmaceutical industry. This framework suggests that drug prices should be a crucial factor in determining whether the public can access taxpayer-funded meds without breaking the bank. More strikingly, it allows government agencies